SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-007444
Filing Date
2020-07-08
Accepted
2020-07-08 09:00:35
Documents
10
Period of Report
2020-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 46731
2 FORM OF PRE-FUNDED WARRANT tenx_ex41.htm EX-4.1 119509
3 FORM OF UNREGISTERED WARRANT tenx_ex42.htm EX-4.2 117631
4 FORM OF PLACEMENT AGENT WARRANT tenx_ex43.htm EX-4.3 121420
5 LEGAL OPINION tenx_ex51.htm EX-5.1 17896
6 SECURITIES PURCHASE AGREEMENT FOR CLASS C tenx_ex101.htm EX-10.1 265185
7 SECURITIES PURCHASE AGREEMENT FOR CLASS E tenx_ex102.htm EX-10.2 272004
8 REGISTRATION RIGHTS AGREEMENT tenx_ex103.htm EX-10.3 175180
9 PRESS RELEASE, DATED JULY 6, 2020 tenx_ex991.htm EX-99.1 14244
10 IMAGE kllogo.jpg GRAPHIC 3191
  Complete submission text file 0001654954-20-007444.txt   1155897
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 201017347
SIC: 8731 Services-Commercial Physical & Biological Research